Yunhai Shengwu: Revolutionizing Biotech with Cutting-Edge Tetrahedron Nucleic Acid Technology
On June 19, 2025, China West Connector had the honor to visit Yunhai Shengwu (Chengdu Yunhai Tetrahedron Biotechnology Co., Ltd.), a leading biotech innovator headquartered in Chengdu, Sichuan Province. Yunhai Shengwu is pioneering the development and industrialization of tetrahedron framework nucleic acid technology, a next-generation platform reshaping drug delivery and biomedical applications.
Breakthrough Science: The Tetrahedron Nucleic Acid Platform
At the core of Yunhai Shengwu’s innovation lies the tetrahedron nucleic acid — a nanoscale, three-dimensional molecular structure engineered from DNA or RNA strands that self-assemble into a highly stable tetrahedral shape. This unique framework offers remarkable advantages:
Exceptional Stability: Unlike traditional linear nucleic acids, the tetrahedron form resists enzymatic degradation in biological environments, enabling prolonged circulation time and enhanced drug stability.
Precise Targeting: The tetrahedral structure can be functionalized with targeting ligands, allowing selective delivery to specific cell types or tissues, minimizing side effects.
Multifunctionality: Its 3D architecture permits simultaneous attachment of therapeutic molecules, imaging agents, or chemical drugs, creating versatile nanocarriers tailored for personalized medicine.
Applications Transforming Biomedicine and Beyond
Yunhai Shengwu’s technology platform is uniquely positioned to transform multiple sectors:
Modernizing Traditional Chinese Medicine (TCM): By integrating natural bioactive compounds into the tetrahedron delivery system, Yunhai enhances their bioavailability and therapeutic effects, bridging ancient wisdom with modern nanotechnology.
Targeted Drug Delivery: Their platform is ideal for precise cancer therapies, gene editing delivery, and antiviral treatments, addressing critical unmet medical needs.
Consumer Health Products: Leveraging their technology in products like the “Qinghe Tetrahedron Scalp Revitalizing Serum,” Yunhai brings advanced molecular science to daily wellness, improving absorption and efficacy of active ingredients.
Leadership and Research Excellence
Yunhai Shengwu was founded by a team of distinguished scientists led by Professor Lin Yunfeng, a pioneer in nucleic acid chemistry and molecular nanotechnology. The company maintains strong collaborations with top-tier academic institutions and research centers, ensuring continuous innovation and rapid technology transfer from bench to market.
Strategic Partnerships and Growth
Since its establishment in early 2024, Yunhai Shengwu has attracted significant investment from prominent funds focused on high-tech biotech ventures. The company actively participates in industry forums such as the “Nucleic Acid Tetrahedron Industrial Development Forum,” sharing knowledge and expanding its network.
Collaboration Between CWC and Yunhai Shengwu
China West Connector (CWC) and Yunhai Shengwu share a common vision of bridging cutting-edge Chinese biotechnology with global markets. As a key connector between Western enterprises and Chinese innovation hubs, CWC supports Yunhai Shengwu in expanding international partnerships, facilitating technology exchange, and promoting their groundbreaking advancements abroad.
Our June 19 visit underscored CWC’s commitment to fostering meaningful collaborations with visionary Chinese companies like Yunhai Shengwu, helping to bring transformative biotech solutions to a global audience. Together, we aim to accelerate the adoption of innovative healthcare technologies and enhance cross-border cooperation in the biotech sector.
A Vision for the Future
China West Connector recognizes Yunhai Shengwu as a visionary leader at the intersection of biotechnology and nanomedicine. Their groundbreaking tetrahedron nucleic acid technology represents a paradigm shift in drug delivery and therapeutic design, with the potential to revolutionize healthcare globally.
We are proud to witness Yunhai Shengwu’s journey and stand ready to support their mission to create innovative, life-enhancing solutions that merge scientific rigor with cultural heritage.
